BB
Belite Bio Inc ADR
🇺🇸XNAS.BLTEUnited StatesHealthcare
$169.21USDdown -0.38 (-0.22%)ClosedEnd of day11:20 PM
Price$169.21-0.38 (-0.22%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US07782B1044
- CUSIP
- 07782B104
Company
- Employees
- 41
- Headquarters
- San Diego, United States
- Website
- https://www.belitebio.com
- CEO
- Dr. Yu-Hsin Lin M.B.A., Ph.D.
Market
- Shares outstanding
- 40.3M
- Market cap
- $6.81B
Key dates
- Next earnings
- Nov 9, 2026
Highlights
- Market cap
- $6.83B
- EPS LTM
- -$2.54calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -66.57calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $00%unchanged year on year
- Net income
- -$102.36M-107.32%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$10.56K+99.77%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.